Jennifer Ling Lee
Insider
First SEC filing: Dec. 7, 2018 · Latest: Dec. 7, 2018
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 9, 2020 | MRNA | S | 361 | $27.33 | $9,866 | 4,419 Direct | -7.55% | Disposed | 632.2% (price as of ) |
| Feb. 28, 2020 | MRNA | A | 16,112 | · | · | 16,112 Direct | · | Acquired | |
| Feb. 28, 2020 | MRNA | A | 8,677 | · | · | 8,677 Direct | · | Acquired | |
| March 8, 2019 | MRNA | A | 4,780 | · | · | 4,780 Direct | · | Acquired | |
| March 8, 2019 | MRNA | A | 25,097 | · | · | 25,097 Direct | · | Acquired | |
| Feb. 20, 2018 | LAB | M | 630 | · | · | 6,307 Direct | +11.10% | Acquired | |
| Feb. 20, 2018 | LAB | M | 1,125 | · | · | 7,432 Direct | +17.84% | Acquired | |
| Feb. 20, 2018 | LAB | F | 716 | $7.81 | $5,592 | 6,716 Direct | -9.63% | Disposed | -92.2% (price as of ) |
| Feb. 20, 2018 | LAB | M | 630 | · | · | 5,670 Direct | -10.00% | Disposed | |
| Feb. 20, 2018 | LAB | M | 1,125 | · | · | 13,126 Direct | -7.89% | Disposed | |
| Nov. 20, 2017 | LAB | M | 630 | · | · | 4,059 Direct | +18.37% | Acquired | |
| Nov. 20, 2017 | LAB | M | 1,125 | · | · | 5,184 Direct | +27.72% | Acquired | |
| Nov. 20, 2017 | LAB | F | 660 | $5.19 | $3,425 | 4,524 Direct | -12.73% | Disposed | -88.2% (price as of ) |
| Nov. 20, 2017 | LAB | M | 630 | · | · | 6,300 Direct | -9.09% | Disposed | |
| Nov. 20, 2017 | LAB | M | 1,125 | · | · | 14,251 Direct | -7.32% | Disposed | |
| Sept. 20, 2017 | LAB | D | 13,400 | · | · | 0 Direct | -100.00% | Disposed | |
| Sept. 20, 2017 | LAB | A | 7,053 | · | · | 7,053 Direct | · | Acquired | |
| Aug. 21, 2017 | LAB | M | 630 | · | · | 2,964 Direct | +26.99% | Acquired | |
| Aug. 21, 2017 | LAB | M | 1,125 | · | · | 4,089 Direct | +37.96% | Acquired | |
| Aug. 21, 2017 | LAB | F | 660 | $3.76 | $2,482 | 3,429 Direct | -16.14% | Disposed | -83.8% (price as of ) |
| Aug. 21, 2017 | LAB | M | 630 | · | · | 6,930 Direct | -8.33% | Disposed | |
| Aug. 21, 2017 | LAB | M | 1,125 | · | · | 15,376 Direct | -6.82% | Disposed | |
| May 22, 2017 | LAB | M | 2,520 | · | · | 2,520 Direct | · | Acquired | |
| May 22, 2017 | LAB | M | 1,499 | · | · | 4,019 Direct | +59.48% | Acquired | |
| May 22, 2017 | LAB | F | 1,685 | $5.46 | $9,200 | 2,334 Direct | -41.93% | Disposed | -88.8% (price as of ) |
| May 22, 2017 | LAB | M | 2,520 | · | · | 7,560 Direct | -25.00% | Disposed | |
| May 22, 2017 | LAB | M | 1,499 | · | · | 16,501 Direct | -8.33% | Disposed | |
| Feb. 13, 2017 | LAB | A | 18,000 | · | · | 18,000 Direct | · | Acquired | |
| Feb. 13, 2017 | LAB | A | 45,400 | · | · | 45,400 Direct | · | Acquired | |
| May 18, 2016 | LAB | A | 10,080 | · | · | 10,080 Direct | · | Acquired | |
| May 18, 2016 | LAB | A | 13,400 | · | · | 13,400 Direct | · | Acquired |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 28, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock | $25.93 | Feb. 28, 2030 | 16,112 | Acquired |
| Feb. 28, 2020 | MRNA | Restricted Stock Units | Common Stock | $0.00 | · | 8,677 | Acquired |
| March 8, 2019 | MRNA | Stock Option (Right to Buy) | Common Stock | $20.93 | March 8, 2029 | 25,097 | Acquired |
| Feb. 20, 2018 | LAB | Restricted Stock Units | Common Stock | · | · | 630 | Disposed |
| Feb. 20, 2018 | LAB | Restricted Stock Units | Common Stock | · | · | 1,125 | Disposed |
| Nov. 20, 2017 | LAB | Restricted Stock Units | Common Stock | · | · | 630 | Disposed |
| Nov. 20, 2017 | LAB | Restricted Stock Units | Common Stock | · | · | 1,125 | Disposed |
| Sept. 20, 2017 | LAB | Employee Stock Option (Right to Buy) | Common Stock | $8.98 | May 18, 2026 | 13,400 | Disposed |
| Sept. 20, 2017 | LAB | Employee Stock Option (Right to Buy) | Common Stock | $5.13 | Sept. 20, 2027 | 7,053 | Acquired |
| Aug. 21, 2017 | LAB | Restricted Stock Units | Common Stock | · | · | 630 | Disposed |
| Aug. 21, 2017 | LAB | Restricted Stock Units | Common Stock | · | · | 1,125 | Disposed |
| May 22, 2017 | LAB | Restricted Stock Units | Common Stock | · | · | 2,520 | Disposed |
| May 22, 2017 | LAB | Restricted Stock Units | Common Stock | · | · | 1,499 | Disposed |
| Feb. 13, 2017 | LAB | Restricted Stock Units | Common Stock | · | · | 18,000 | Acquired |
| Feb. 13, 2017 | LAB | Stock Option (Right to Buy) | Common Stock | $6.16 | Feb. 13, 2027 | 45,400 | Acquired |
| May 18, 2016 | LAB | Restricted Stock Units | Common Stock | · | · | 10,080 | Acquired |
| May 18, 2016 | LAB | Employee Stock Option (Right to Buy) | Common Stock | $8.98 | May 18, 2026 | 13,400 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Dec. 7, 2018 | MRNA | Stock Option (Right to Buy) | 50,458 | Direct |